A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Principal results

Heart

Volumn 75, Issue 4, 1996, Pages 334-342

  Bowker, T J ^a,b   Clayton, T C ^a,b   Ingham, J ^a,b   McLennan, N R ^a,b   Hobson, H L ^a,b   Pyke, S D M ^a,b   Schofield, B ^a,b   Wood, D A ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Coronary disease; Secondary prevention; United Kingdom survey

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ASPIRIN; CARDIAC CARE FACILITIES; CARDIOLOGY; CHOLESTEROL; CORONARY DISEASE; DATA COLLECTION; FEMALE; GREAT BRITAIN; HEALTH SURVEYS; HOSPITALS, DISTRICT; HOSPITALS, GENERAL; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; RECURRENCE; RISK FACTORS; SMOKING; SOCIETIES, MEDICAL;

EID: 0029889668     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.4.334     Document Type: Article

References (17)

1. The British Cardiac Society Working Group on Coronary Prevention: conclusions and recommendations. Br Heart J 1987;57:188-9.
2. Burr ML, Gilbert JF, Holliday RM, Elwood PC, Fehily AM, Rogers S, et al. Effects of changes in fat, fish and fibre intakes on death and myocardial infarction; diet and reinfarction trial (DART). Lancet 1989;ii:757-61.
3. Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Maonjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-9.
4. O'Connor GT, Buring JF, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger Jr RS, Hennekens CH. An overview of randomised trials of rehabilitation with exercise after myocardial infarction. Circulation 1989; 60:234-44.
5. Collins R, Peto R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
6. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308:367-73.
7. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344: 1383-9.
8. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
9. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327: 669-77.
10. AIRE (Acute Infarction Ramipril Efficacy) Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
11. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990;323:147-52.
12. Aberg A, Bergstrand R, Johansson S, Ulvenstam G, Vedin A, Wedel H, et al. Cessation of smoking after myocardial infarction. Effects of mortality after 10 years. Br Heart J 1983;49:416-22.
13. Leren P. The Oslo Diet-Heart Study: eleven-year report. Circulation 1970;42:935-42.
14. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993;306:983-7.
15. Betteridge DJ, Dodcon PM, Durrington PN, Hughes EA, Laker ME, Nicholls DP, et al. Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. Postgrad Med J 1993;69:359-69.
16. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 1983;37:335-71.
17. Pyöräla K, De Backer G, Graham I, Poole-Wilson PA, Wood DA on behalf of the Task Force. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15:1300-31.